<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: AMRN News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=amrn</link><description>Latest Financial News for Amarin Corporation PLC</description><language>en-us</language><lastBuildDate>Wed, 2 Dec 2009 08:30:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091202/20091202005371.html?.v=1</link><description>DUBLIN &amp; MYSTIC, Conn.----Amarin Corporation plc , a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced Joseph S. Zakrzewski will join the Company’s Board of Directors as Executive Chairman effective January 1, 2010.</description><guid isPermaLink="false">yahoo_finance/1736369437</guid><pubDate>Wed, 2 Dec 2009 08:30:00 Etc/GMT</pubDate></item><item><title>Amarin Announces Notice of Annual General Meeting (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091123/20091123005348.html?.v=1</link><description>DUBLIN----Amarin Corporation plc announced today that it has sent to its shareholders a Notice of the Annual General Meeting of the Company, which will be held on December 21, 2009 in Dublin, Ireland.</description><guid isPermaLink="false">yahoo_finance/132597509</guid><pubDate>Mon, 23 Nov 2009 11:15:00 Etc/GMT</pubDate></item><item><title>Amarin Appoints John F. Thero as Chief Financial Officer (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091106/20091106005031.html?.v=1</link><description>DUBLIN----Amarin Corporation plc today announced the appointment of John F. Thero as the Companyâs Chief Financial Officer. In this role, Mr. Thero will have broad responsibility for financial and administrative matters of the Company and be actively involved in corporate development and other strategic and operational matters.</description><guid isPermaLink="false">yahoo_finance/117058344</guid><pubDate>Fri, 6 Nov 2009 09:15:00 Etc/GMT</pubDate></item><item><title>AMARIN CORP PLC\UK Financials (EDGAR Online Financials)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=amrn&amp;annual</link><description></description><guid isPermaLink="false">yahoo_finance/2438965741</guid><pubDate>Tue, 27 Oct 2009 13:04:37 Etc/GMT</pubDate></item><item><title>Amarin Announces Completion of $70 Million Private Placement (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091019/20091019005819.html?.v=1</link><description>DUBLIN----Amarin Corporation plc today announced it has closed its $70 million private placement. The transaction was led by existing investor, Fountain Healthcare Partners, on behalf of funds affiliated with other existing investors Sofinnova Ventures, Orbimed Advisors and Longitude Capital.</description><guid isPermaLink="false">yahoo_finance/1685235204</guid><pubDate>Mon, 19 Oct 2009 12:42:00 Etc/GMT</pubDate></item><item><title>Amarin Appoints Medpace as CRO for Two Phase 3 Cardiovascular Trials (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091019/20091019005809.html?.v=1</link><description>DUBLIN----Amarin Corporation plc today announced that it has executed an agreement with Medpace, Inc. , a leading Contract Research Organization with expertise in conducting clinical trials in cardiovascular and metabolic disease, to engage their services in the execution of its Phase 3 clinical trials with AMR101 in patients with very high triglyceride levels and mixed dyslipidemia.</description><guid isPermaLink="false">yahoo_finance/1265004679</guid><pubDate>Mon, 19 Oct 2009 12:35:00 Etc/GMT</pubDate></item><item><title>Amarin Announces Changes to Its Board and Management Team (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091013/20091013005699.html?.v=1</link><description>DUBLIN----Amarin Corporation plc today announced changes to its board and management team, in conjunction with its separately announced $70 million private placement.</description><guid isPermaLink="false">yahoo_finance/3788375982</guid><pubDate>Tue, 13 Oct 2009 12:58:00 Etc/GMT</pubDate></item><item><title>Amarin Announces $70 Million Private Placement (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091013/20091013005695.html?.v=1</link><description>DUBLIN----Amarin Corporation plc today announced it has entered into a definitive agreement with several existing and new institutional and accredited investors for a $70 million private placement.</description><guid isPermaLink="false">yahoo_finance/626448690</guid><pubDate>Tue, 13 Oct 2009 12:55:00 Etc/GMT</pubDate></item><item><title>Amarin Receives Extension from Nasdaq to File Its 2008 Annual Report on Form 20-F (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091005/20091005005732.html?.v=1</link><description>DUBLIN----Amarin Corporation plc today announced that Nasdaq has granted the Company’s requested extension to the deadline to file its 2008 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission to regain compliance with Nasdaq&apos;s filing requirements for continued listing.</description><guid isPermaLink="false">yahoo_finance/1188317308</guid><pubDate>Mon, 5 Oct 2009 11:56:00 Etc/GMT</pubDate></item><item><title>Amarin Announces Extension to Bridge Financing (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091001/20091001005604.html?.v=1</link><description>DUBLIN----Amarin Corporation plc today announced that it has reached an agreement with the lenders of the Companyâs $5.5 million bridge financing to extend the maturity date to October 16, 2009.</description><guid isPermaLink="false">yahoo_finance/1134713614</guid><pubDate>Thu, 1 Oct 2009 12:23:00 Etc/GMT</pubDate></item></channel></rss><!-- c7.finance.sp2.yahoo.com compressed/chunked Sun Dec 27 02:28:32 PST 2009 -->
